Treatment of Experimental Human Mesothelioma Using Adenovirus Transfer of the Herpes Simplex Thymidine Kinase Gene

Authors:
  • HHHarry C. Hwang
    Harry C. Hwang
  • AEAshraf A. Elshami
    Ashraf A. Elshami
  • KAKunjlata M. Amin
    Kunjlata M. Amin
  • SEStephen L. Eck
    Stephen L. Eck
  • BDBeverly L. Davidson
    Beverly L. Davidson
  • LKLarry R. Kaiser
    Larry R. Kaiser
  • SASteven M. Albeida
    Steven M. Albeida

Abstract
The authors demonstrate the ability of an adenovirus vector expressing the herpes simplex thymidine klnase (HSV tk) gene to treat human malignant mesothelioma growing within the peritoneal cavity of severe combined immunodeficient (SCID) mice. Introduction of the HSV tk gene into tumor cells renders them sensitive to the antiviral drug ganciclovir (GCV). This approach has been used previously to treat experimental brain tumors. Although malignant mesothelioma is refractory to current therapies, its localized nature and the accessibility of the pleural space make it a potential target for a similar type of in vivo gene therapy using adenovirus. An adenovirus containing the HSV tk gene (Ad.RSV tk) was used to transduce mesothelioma cells in vitro. These cells were then injected into the flanks of SCID mice. Ad.RSV tk was also injected directly into the peritoneal cavity of SCID mice with established human mesothelioma tumors. Mice were subsequently treated for 7 days with GCV at a dose of 5 mg/kg. Mesothelioma cells transduced in vitro with Ad.RSV tk formed nodules when injected in the subcutaneous tissue. These tumors could be eliminated by the administration of GCV, even when as few as 10% of cells were transduced to express HSV tk (bystander effect). Administration of Ad.RSV tk into the peritoneal space of animals with established multifocal human mesothelioma followed by GCV therapy resulted in the eradication of macroscopic tumor in 90% of animals and microscopic tumor in 80% of animals when evaluated after 30 days. The median survival of animals treated with Ad.RSV tk/GCV was significantly longer than that of control animals treated with similar protocols.

This publication has 30 references indexed in Scilit: